DV
Dividend Vision

KRYS — Krystal Biotech Inc.

Krystal Biotech Inc. (KRYS)

Total return is 3022.8% over the past 8.9 years, 2767.3 points ahead of SPY at 255.5%. Its deepest 1-year drawdown was 17.3%.

KRYS is a single-stock equity fund focused on Krystal Biotech Inc., a biotechnology company. As a concentrated position in a non-dividend-paying stock, it does not currently distribute income and carries no listed expense ratio or distribution frequency. This fund appeals primarily to investors seeking exposure to a specific biotech company rather than those focused on dividend income.

KRYS key facts

Asset type
Stock
Asset class
Equity
Inception date
09/20/2017
Distribution frequency
None
Last close
$332.27
Market cap
$9,834,805,248
Average volume
167900.0
Beta
0.536
Payout ratio
0.0
P/E ratio
41.1735
Forward P/E
43.29
EPS
$8.07